How Does The Clearmind Medicine (CMND) Stock Price Increase By 10% In Extended Session?

As a result of the biotech company hiring an experienced CEO, Clearmind Medicine Inc. (NASDAQ: CMND) has increased 10.00% to $3.30 in after-hours trading on the latest check Friday.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


A CMND appointment, which one?

Nicholas Kadysh, a seasoned regulatory executive, has been appointed by Clearmind Medicine (CMND) as a special advisor for the advancement of MEAI as an alcohol alternative.

Kadysh is a professional specialist in navigating difficult regulatory problems in the health and food industries. She was a previous executive at Red Bull Canada and Juul Labs Canada. He is also the Board Director of Psychedelics Canada, the business group for the for-profit, lawful Canadian psychedelic drugs sector, and the creator of PharmAla Biotech, which produces MDMA- and MDXX-class compounds for medicinal research.

Kadysh will contribute his wide expertise and provide a significant understanding of corporate affairs and laws to CMND’s alcohol alternative program. In addition to creating a parallel track for MEAI’s use as an alcohol substitute, CMND is also developing its original, revolutionary psychedelic-derived medication candidate MEAI for addiction treatment. The safety studies are now being conducted for this by CMND.

Sales of non-alcoholic beverages are increasing significantly, according to NielsenIQ, a global provider of information services. The total dollar sales of non-alcoholic beverages in the US between August 2021 and August 2022 reached $395 million, an increase of almost 21% year over year.

CNMD is moving closer to conducting human clinical trials

The MEAI-based chemical CMND-100, a novel psychedelic-derived medication candidate, is already being produced in clinical quantities, according to a recent announcement by CMND. The manufactured batches will be utilized in a forthcoming first-in-human (FIH) clinical trial by CNMD to assess the efficacy of the candidate medicine, CMND-100, for the management of alcohol use disorder (AUD).

The molecule is being manufactured in accordance with GMP (Good Manufacturing Process) guidelines in order to meet FDA criteria after going through MEAI’s synthesis development process. Because Clearmind Medicine (CMND) had produced MEAI medicinal material successfully, it was able to utilize it in pre-clinical tests to test the safety of its novel molecule. This allowed for the manufacture of clinical batches.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...

5 Best Stocks to Trade in Premarket Movers Today

Pre-market is a period of time where trading activity...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

8.76% percent quarterly performance for ICICI Bank Limited (IBN) is not indicative of the underlying story

ICICI Bank Limited (NYSE: IBN) kicked off on June 02, 2023, at the price of $22.97, up 0.43% from the previous trading day. During...

The Interpublic Group of Companies Inc. (IPG) is 5.20% away from 50-day simple Moving Average despite all headwinds

The Interpublic Group of Companies Inc. (NYSE: IPG) on June 02, 2023, started off the session at the price of $37.90, soaring 2.44% from...

No matter how cynical the overall market is, OptiNose Inc. (OPTN) performance over the last week is recorded -4.72%

June 02, 2023, OptiNose Inc. (NASDAQ: OPTN) trading session started at the price of $1.22, that was -3.20% drop from the session before. During...


Please enter your comment!
Please enter your name here